Retired
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yep I did, but I made sure to end with the positive. ;)
I worked with the WGT types most often in my role as a margin clerk. Some just can't stop themselves from using leverage.
My advice is pretty even keeled and always suitable for the circumstances.
Based on my DD there are valid reasons to have a WGT opinion for Rett.
Just to clarify, BlackRock, Vanguard and State Street participation in $AVXL is primarily as part of their indexed fund offerings with little to no analysis at the company level.
Now that said, on the positive side, one can see that the number of much smaller reporting holders has increased steadily over time. Hedge funds and Family offices do take notice of company level activities and have initiated positions.
I also wanted to point out that de-risking can occur at any time and should be tailored to the specific situation of the client. Using options to create collars is a tactic I've recommended to some.
LOL, I used to have clients that would spin their trading fantasies to me. I'd have to stop and remind them they are talking to their broker and to save their tall tales and half truths for their spouses and bar buddies. Today it's probably their pickleball people.
Of course that was in the old days when people used human brokers.
My time horizon is long and my DD deep and the day to day is of no concern to me.
True it is Tuesday and I welcome a material news event, but I don't use hope as an investment plan.
Nibble, nibble, nibble, because scared money don't make money.
What's tricky IMO is that on the wider level the $XBI and small cap risk equity in general are struggling to find direction and if the $XBI rolls lower $AVXL will be dragged down with it without a positive material news event.
All few of my programs and gut instinct put support at $7.99 and I put my money where my chat is and added at $7.99. This buy was obviously not based on technical, but instead on my tendency to buy support lines on stocks I like loner term or with pending event news.
Today the range was $7.91-$8.21 with a close at $8.17. We shall see if it holds. I recommended to others without the comfort level for gambling risk to use the BUY STOP order to catch the upside. I've been very successful using that order type trading $AVXL in the past.
It doesn't get more neutral and it's making the extremes lose their minds.
LOL, it quite entertaining
S1R as a therapeutic target is represented in a few of those companies is definitely worth a mention.
It probably is, these chat boards have existed long before "meme stock" mania, and the before the pot stock green rush. Making the spread was good money to ya know. I'm sure old timers here have stories.
I'm going too off topic, but remember the context. My comment was in general and in relation to the fact iHub is primarily penny stock forum. I'm frankly glad it's here in spite of my complaining. LOL!
It's these extreme differences in valuations between sectors and the general market is where I made my first big wins. It's due time for the $XBI to catch up.
Positive news out of $AVXL along with the louder beating of team amyloid drum should increase capital flow towards the sector. Love them or hate them team amyloid is producing positive spin with their marginal efficacy to reduce cognitive decline.
Good luck to those wealthy enough and brave enough to take on the risk to roto-router out your brain matter. I'll wait for better and safer therapies such as blarcamesine.
I'd make the attempt but I would have to go too far off topic to explain payment for order flow and how equity markets have changed since electronic trading and the history of chat boards.
The real mission of these chat boards is to generate order flow of both buys and sells. $AVXL is an oddball on what is otherwise a penny stock venue, but the mission is the same. Create drama, evoke emotions, encourage trades.
Many of us took profits including the CEO back then. Times were good and the exuberance was at it's prime. $AVXL even filled the coffers with $150 million in cash. To say "Investor" made an outstanding call is nothing special as selling stock was the thing to do at that time. That was then, this is now.
AAIC was a bore, time for $AVXL to shine.
On the positive side, the mods do enforce "on topic" well.
True, but what's funny is I very frequently will click back on a response and read the ignored poster anyway.. LOL!
I like to read as many valid opinions as possible.
I'm a simpleton when it comes to biology, but I'm definitely not one when it comes to wealth management, so I value the quality contributions in topics I lack in.
iHub relies on ad revenue traffic and felt the need to keep up with stocktwits, hence the allowance of personal attacks. The era of non-personal attack trolling is over. It's a race to the bottom.
Or those who would have been his counterparty at capital firms were laid of in the investment bank downsizing of late.
I've been concerned about equity capital markets and the availability of capital for a couple years now and looking at the news and industry rags, biotech is in for some lean times.
Good thing $AVXL and a few others raised cash when the market was frothy.
New and unimproved iHub, now includes the fun of personal attacks...
I was a moderator/admin on this group and a "green rush" penny stock ($TRTC/$UNRV), which I trolled into the ground and saved many people from investing in its lies masqueraded in "forward looking statements" and rosy projections after the pump period was over and financial realities set into the sector.
This board has a few god posters, but doubtful it's still worth sifting through the multiple worthless trolling posts. The signal to noise ratio is getting smaller and that's unfortunate for new investors.
Definitely a most entertaining board.
LOL, just because you don't have the skill set for such earnings, don't take it out on another's success. Wealth envy is a weak bitch, as he earned it fair and square.
Combine that with Stanford president resignation and it's not a good look for the industry and/or academia.
Often times taxes are paid at the top rate and the cost basis is the same as the transaction often times market price.
But, I'm not a tax guy and situations can be different and laws change.
In your zealousness to spin the negative, try not to lie going forward.
In your zealousness to spin the negative, try not to lie going forward.
Indeed it was a neutral event and my viewpoint is similar to what I would recommend if Dr. M was my personal client, and that would have been at this juncture, a cashless exercise. Dr.M has a long tenure planned and lots of stock options available to reward him as per his employment contract.
$AVXL is a hobby stock of mine, a million dollar hobby, but it's a hobby. This message board is frequently toxic and it appears from the posts I've skimmed the rules have changed to be more toxic.
Between iHub, Stocktwits, and the FB group, each one has it's pros and cons.
Seek out the Facebook group if you want to further engage in positive dialogues. I'm one of the original creators and admin of the group. (It's a real person group, with real people not aliases). Fun factoid, It's where SOTC (Spirit of the Coast Analytics), the public facing entity of Mr. Mayomobile the smartest "kid" I've met in a long time, got it's start.
Actually the Doc's opinion agrees with mine in that the transaction was a neutral event as part of the CEO's compensation, and makes sense for clients who have many stock option grants as a part of their compensation.
"To say "it was a gift" was a lie and here you go with more attempts to minimize and spin every event toward the negative.
To say "it was a gift" is a lie and wrong. It wasn't a gift. He received shares as part of his complementation plan.
Also, the cashless exercises made sense and IMO was the best option for Dr.M on a personal level. This is particularly true in his situation as stock option are a large part of his compensation and has many more option grants banked, and more to come as milestones are met.
At least I don't post the same drivel daily. The daily canned sniping and crying has the same effect as FUD.
Plenty of canned assumptions of next type of trial will be next too.
Hey Cornflakes, I have been "sucking it up" since 2015.
canned complaining on your part make one look like a blowhard...
Also what keeps getting missed in this discussion is that the value of the option grant is the CEO's FAIR and DUE compensation per his employment agreement written many, many years ago when $AVXL was a true OTC penny stock.
Bravo to Dr. M he earned it and good for him that he exercised in his own extremely rational way (cashless exercise) to add to his personal holdings.
Most long timers here before 2021 should be at worst, break even. Those like myself holding large profits also sold covered calls during the "irrational times". I can wait for the longer term value of blarcamesine to play out according to the CEO's instincts to unlock long term value.
Suck it up, biotech isn't for everyone. Don't blame poor investment selection and expectations on the CEO. First mistake is to assume there has been a "lack of progress".
It's been a long 8 years for me, but I too have learned more than when I arrived.
Plus, $AVXL is a much more fun story to tell.
Scrappy $AVXL the reverse merger, reverse split, OTC trading upstart who uplisted to NASDAQ versus "big money"
A couple of points as I also own $ACAD and advocate for the rare disease communities. The approval of Trofinetide was a major event being first to market and exciting for the community to finally have a drug to try. I personally wish them all the best with the treatment and working through the adverse side effects. Sales will flatten out after the initial surge. IMO, the key market cap driver for $ACAD is the growing prescribing rate for Nuplazid, Trofinetide was a nice bonus.
My father technically had Lewy Body Dementia one of the diseases associated with Neurological Synuclein Disease (NSD). Expect to see this term NSD used more in the literature, probably starting next year, as the Michael J Fox Foundation and many other stakeholders are making attempts to better understand and diagnose the diseases caused by alpha-synuclein misfolding. This project will improve availability and further fuel Nuplazid sales growth.
Blarcamesine has a completely different mechanism of action and will be a complementary treatment used with both Nuplazid and Trofinetide and more than likely blarcamesine will become the first line treatment.